cemacabtagene ansegedleucel vs anti-cd52 monoclonal antibody allo-647
| cemacabtagene ansegedleucel | anti-cd52 monoclonal antibody allo-647 | |
|---|---|---|
| Developers | 0 | 0 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | Cemacabtagene Ansegedleucel | Anti-CD52 Monoclonal Antibody ALLO-647 |